Literature DB >> 18270679

Activation of phosphoinositide 3-kinase by the NBS1 DNA repair protein through a novel activation motif.

Yen-Chung Chen1, Hsiu-Yin Chiang, Muh-Hwa Yang, Po-Min Chen, Shyue-Yih Chang, Shu-Chun Teng, Bart Vanhaesebroeck, Kou-Juey Wu.   

Abstract

Class IA phosphoinositide 3-kinases (PI 3-kinases) are key signaling components downstream of tyrosine kinases and Ras, regulating many different cellular functions and contributing to tumorigenesis. Class IA PI 3-kinases are heterodimers comprised of a p85 regulatory and a p110 catalytic subunit. Nijmegen breakage syndrome (NBS) is a chromosomal instability syndrome associated with cancer predisposition, radiosensitivity, microcephaly, and growth retardation. The NBS gene product p95 (also known as NBS1) is part of the Mre11-Rad50-Nbs1 complex, a central player associated with double-strand break repair. We previously demonstrated that NBS1 overexpression induces transformation through activation of PI 3-kinase/Akt. In this study, we show that NBS1 directly interacts, through a highly conserved C-terminal motif (aa 653-669) of NBS1, with the N-terminal domain (aa 1-108) of the p110alpha catalytic subunit of PI 3-kinase, and stimulates PI 3-kinase activity. Mutations of different regions of the conserved motif abolish the ability of NBS1 to activate PI 3-kinase in vitro and in vivo. Co-expression of NBS1/p110alpha/p-Akt is observed in certain percentage of head and neck cancer patient samples. These results demonstrate that NBS1 can function as an adaptor/activator of p110alpha PI 3-kinase through a novel activation motif, consistent with its possible role in cell transformation and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18270679     DOI: 10.1007/s00109-008-0302-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  32 in total

Review 1.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

Review 2.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

Authors:  Ji Luo; Brendan D Manning; Lewis C Cantley
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

Review 3.  Signalling through Class I PI3Ks in mammalian cells.

Authors:  P T Hawkins; K E Anderson; K Davidson; L R Stephens
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

4.  Akt activation by growth factors is a multiple-step process: the role of the PH domain.

Authors:  A Bellacosa; T O Chan; N N Ahmed; K Datta; S Malstrom; D Stokoe; F McCormick; J Feng; P Tsichlis
Journal:  Oncogene       Date:  1998-07-23       Impact factor: 9.867

5.  Pike. A nuclear gtpase that enhances PI3kinase activity and is regulated by protein 4.1N.

Authors:  K Ye; K J Hurt; F Y Wu; M Fang; H R Luo; J J Hong; S Blackshaw; C D Ferris; S H Snyder
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

6.  Expression pattern of the Nijmegen breakage syndrome gene, Nbs1, during murine development.

Authors:  M Wilda; I Demuth; P Concannon; K Sperling; H Hameister
Journal:  Hum Mol Genet       Date:  2000-07-22       Impact factor: 6.150

7.  Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt.

Authors:  Yen-Chung Chen; Yi-Ning Su; Po-Chien Chou; Wei-Chung Chiang; Ming-Cheng Chang; Liang-Shun Wang; Shu-Chun Teng; Kou-Juey Wu
Journal:  J Biol Chem       Date:  2005-07-21       Impact factor: 5.157

Review 8.  Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks.

Authors:  Martin Digweed; Karl Sperling
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

9.  c-Myc directly regulates the transcription of the NBS1 gene involved in DNA double-strand break repair.

Authors:  Yu-Chi Chiang; Shu-Chun Teng; Yi-Ning Su; Fon-Jou Hsieh; Kou-Juey Wu
Journal:  J Biol Chem       Date:  2003-03-13       Impact factor: 5.157

10.  p84, a new Gbetagamma-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110gamma.

Authors:  Sabine Suire; John Coadwell; G John Ferguson; Keith Davidson; Phillip Hawkins; Len Stephens
Journal:  Curr Biol       Date:  2005-03-29       Impact factor: 10.834

View more
  13 in total

1.  Nuclear phosphoinositide 3-kinase beta controls double-strand break DNA repair.

Authors:  Amit Kumar; Oscar Fernandez-Capetillo; Oscar Fernadez-Capetillo; Ana C Carrera
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

Review 2.  MRN and the race to the break.

Authors:  Agnieszka Rupnik; Noel F Lowndes; Muriel Grenon
Journal:  Chromosoma       Date:  2009-10-28       Impact factor: 4.316

3.  Structural mechanism of ATP-dependent DNA binding and DNA end bridging by eukaryotic Rad50.

Authors:  Florian Ulrich Seifert; Katja Lammens; Gabriele Stoehr; Brigitte Kessler; Karl-Peter Hopfner
Journal:  EMBO J       Date:  2016-02-19       Impact factor: 11.598

4.  UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy.

Authors:  L Hu; X Li; Q Liu; J Xu; H Ge; Z Wang; H Wang; Z Wang; C Shi; X Xu; J Huang; Z Lin; R O Pieper; C Weng
Journal:  Oncogene       Date:  2016-09-05       Impact factor: 9.867

5.  Nuclear export of NBN is required for normal cellular responses to radiation.

Authors:  Christine S Vissinga; Tiong C Yeo; Sarah Warren; James V Brawley; Jennifer Phillips; Karen Cerosaletti; Patrick Concannon
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 4.272

6.  Ribavirin targets eIF4E dependent Akt survival signaling.

Authors:  Keith Tan; Biljana Culjkovic; Abdellatif Amri; Katherine L B Borden
Journal:  Biochem Biophys Res Commun       Date:  2008-08-14       Impact factor: 3.575

Review 7.  Pondering the puzzle of PML (promyelocytic leukemia) nuclear bodies: can we fit the pieces together using an RNA regulon?

Authors:  Katherine L B Borden
Journal:  Biochim Biophys Acta       Date:  2008-06-18

8.  Induction of HSPA4 and HSPA14 by NBS1 overexpression contributes to NBS1-induced in vitro metastatic and transformation activity.

Authors:  Chung-Yin Wu; Chih-Ta Lin; Min-Zu Wu; Kou-Juey Wu
Journal:  J Biomed Sci       Date:  2011-01-06       Impact factor: 8.410

9.  Molecular disruption of NBS1 with targeted gene delivery enhances chemosensitisation in head and neck cancer.

Authors:  K Araki; T Yamashita; N Reddy; H Wang; W M Abuzeid; K Khan; B W O'Malley; D Li
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

10.  Interaction between NBS1 and the mTOR/Rictor/SIN1 complex through specific domains.

Authors:  Jian-Qiu Wang; Jian-Hong Chen; Yen-Chung Chen; Mei-Yu Chen; Chia-Ying Hsieh; Shu-Chun Teng; Kou-Juey Wu
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.